Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Allergy & Immunology
•
Immunosuppression
•
Anaphylaxis
•
Allergy
•
Immunology
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Patient with seropositive RA, immunodeficiency, and idiopathic anaphylaxis.
Related Questions
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?